Aprea Therapeutics Inc (NAS:APRE)
$ 3.3 0.16 (5.1%) Market Cap: 17.07 Mil Enterprise Value: -11.72 Mil PE Ratio: 0 PB Ratio: 0.78 GF Score: 37/100

Aprea Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 09, 2021 / 01:00PM GMT
Release Date Price: $100 (+1.83%)
Christian S. Schade
Aprea Therapeutics, Inc. - President, CEO & Chairman

Thank you, operator. And good morning, everyone. This meeting is officially called to order.

I am Christian Schade, the Chairman and Chief Executive Officer of Aprea, and I want to welcome you to our 2021 Annual Meeting of Stockholders.

Scott Coiante, our Senior Vice President and Chief Financial Officer, will act as Secretary of the meeting.

In light of the continuing COVID-19 pandemic, we have chosen to conduct the annual meeting in a virtual format. We are pleased to be able to hold a meeting that stockholders can attend virtually, enabling everyone to engage with the company while staying safe and maintaining appropriate social distancing.

And with that, I will turn the meeting over to the Secretary for some brief introductory comments.

Scott M. Coiante
Aprea Therapeutics, Inc. - Senior VP, Company Secretary & CFO

Thank you.

The rules of conduct and procedures for this meeting are posted on the web portal. As stated in those

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot